securities litigation

Three shareholder lawsuits filed against $BRBR, $BYND, and $METC over alleged sales misstatements, asset valuations, and mine development disclosures. Lead plaintiff deadlines announced; affected investors encouraged to seek legal representation.

Shareholder lawsuits target Kyndryl and uniQure with lead plaintiff deadlines approaching April 2026. Investors must act quickly to join litigation.

BioXcel Therapeutics settles $9.75M class action over securities purchased March-June 2023. Fairness hearing scheduled September 2026.

Federal court certifies class action against Biogen for alleged 2021 securities misrepresentations, affecting purchasers during June-July period.

Shareholder lawsuits against Nektar Therapeutics ($NKTR) and Eos Energy ($EOSE) allege clinical trial and production capacity disclosure failures, with lead plaintiff deadlines in April-May 2026.

Shareholder lawsuits target $KD and $QURE over alleged disclosure violations, with lead plaintiff applications due April 13, 2026. Affected investors may pursue recovery.

Monteverde & Associates investigates four mergers including $TALK's $5.25/share sale to UHS, plus deals involving $ALIS, $JTAI, and $RLYB.

Nektar Therapeutics faces securities class action over alleged misstatements about REZOLVE-AA trial, with stock falling 7.77% after trial failure announcement.

Class action lawsuits filed against Paysafe and Oracle alleging material disclosure failures. Paysafe stock fell 27.6% on undisclosed risks; Oracle faces allegations over understated AI CapEx requirements.

Class action lawsuit filed against Picard Medical for fraudulent stock promotion scheme. Stock crashed 70% to $2.00/share. Investor deadline April 3, 2026.

Class action lawsuit filed against Ardent Health for allegedly inflating receivables. Stock plunged 34% after $43M revenue decrease revealed in Q3 2025.

Pomerantz LLP investigates potential investor claims against Aardvark Therapeutics and FS KKR Capital Corp, while retracting prior Ambarella notice.

Federal court approves $1.6M class action settlement for Cummins investors. Settlement fairness hearing scheduled May 2026; claim deadline April 23, 2026.

Kaskela Law LLC investigates KORE Group's $9.25 per share acquisition by Searchlight Capital and Abry Partners, questioning transaction fairness and potential fiduciary breaches.

Law firm investigates whether European Wax Center's $5.80/share buyout offer adequately values shareholders, citing analyst price targets over 150% higher.

Kaskela Law investigates whether Clearwater Analytics' $24.55/share buyout offer is fair, noting analysts target $35+, implying 43% potential undervaluation.

Class action lawsuit filed against Ardent Health for accounting irregularities. Stock tumbled 34% after $43M revenue decrease discovery. Lead plaintiff deadline: March 9, 2026.

Law firm investigates Mister Car Wash's take-private transaction at $7 per share for potential fiduciary duty violations by board and controlling shareholder.

Shareholder lawsuits filed against CoreWeave, Bath & Body Works, and Vistagen for alleged disclosure violations. Lead plaintiff deadlines set for March 2026.

Law firm announces March 9, 2026 deadline for shareholders to seek lead plaintiff status in securities class actions against Ardent Health and Varonis Systems over alleged misstatements.